drugset / Trial / NCT06512883
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of study is to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of benralizumab.
Timeline
- Start
- 2025-04-17
- Primary completion
- 2028-02-20
- Completion
- 2029-05-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benralizumab | Monoclonal antibody | — | Subcutaneous |